Phase I Clinical Trial to Evaluate Dimethylfumarate (DMF) in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 27 Jun 2016 Status changed from not yet recruiting to recruiting.
- 10 Jun 2016 New trial record